Tranexamic acid for anaemia in women
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This trial tests whether tranexamic acid, a medicine that helps reduce bleeding, can improve anaemia (low blood iron) in women with heavy periods. If you have anaemia and heavy menstrual bleeding, this treatment might help raise your iron levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older.
- You must be currently having periods that come at least every 38 days and last at least 2 days.
- You must have anaemia (low blood iron), confirmed by a finger-prick test at screening.
- You must not be planning to get pregnant during the trial.
- You must not be currently taking tranexamic acid, and you must not have conditions that make this drug unsafe (like blood clots, kidney problems, or a history of seizures).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
This trial tests whether giving tranexamic acid during a C-section can reduce the risk of heavy bleeding after childbirth. It may help women who have certain risk factors for postpartum hemorrhage.
This trial is testing if a medicine called tranexamic acid (TXA) can help reduce bleeding during a second-trimester abortion or miscarriage procedure. The goal is to make the procedure safer for patients.
This trial tests if tranexamic acid, a medicine that helps blood clot, can reduce bleeding in people with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who have very low platelet counts and are receiving less-intensive chemotherapy.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
Hear when a new Anaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.